Linical (2183) · RiskMaterialised
Impact of South Korea’s medical strike on orders and clinical trial progress
First written in FY2025-H1. 1 of 2 entries say "Materialised", first in FY2026-H1. Latest entry: FY2026-H1.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Stagnation in order intake and clinical trial progress due to the medical strike in South KoreaA theme 1 companies write about · 1 as a headwind · 0 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2026-H1MaterialisedAnnual report
「In South Korea, the medical strikes that occurred in the previous fiscal year continued to affect the progress of existing trials and the acquisition of new projects. In addition, several existing projects were suspended at the customers’ request, resulting in lower revenue year on year, but the operating loss narrowed because the group restrained costs incurred.」
The description states that the medical strikes in South Korea that occurred in the previous fiscal year continued to affect the progress of existing trials and the acquisition of new projects. - FY2025-H1First statedAnnual report
「The ongoing medical strikes in South Korea are affecting the acquisition of new projects and the progress of existing projects, and we are closely monitoring developments.」
The ongoing medical strikes in South Korea are described as a new region-specific risk affecting the acquisition of new projects and the progress of existing projects.